malondialdehyde has been researched along with aprepitant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cadirci, E; Halici, Z; Kahramanlar, A; Kose, D; Tastan, TB; Ugan, RA; Un, H | 1 |
1 other study(ies) available for malondialdehyde and aprepitant
Article | Year |
---|---|
Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antiemetics; Antioxidants; Aprepitant; Cecum; Disease Models, Animal; Female; Glutathione; Inflammation; Ligation; Lung; Malondialdehyde; NF-kappa B; Oxidative Stress; Peroxidase; Rats, Sprague-Dawley; Sepsis; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2021 |